Arkadios Wealth Advisors’s VanEck Pharmaceutical ETF PPH Stock Holding History

Arkadios Wealth Advisors’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$926K	Buy	8,469 +22	+0.3%	+$2.28K	0.01%	837
2026 Q1	$877K	Buy	8,447 +150	+2%	+$16K	0.01%	848
2025 Q4	$856K	Buy	8,297 +607	+8%	+$59K	0.02%	766
2025 Q3	$695K	Sell	7,690 -90	-1%	-$7.88K	0.02%	798
2025 Q2	$684K	Buy	+7,780	New	+$674K	0.02%	730

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Arkadios Wealth Advisors's PPH Position: Q2 2026 in Review

Arkadios Wealth Advisors increased its VanEck Pharmaceutical ETF (PPH) stake by 0.26% in Q2 2026, buying an estimated $2.28K and bringing the position to 8,469 shares worth $926K. The position accounts for 0.01% of the portfolio, ranked #837.

Arkadios Wealth Advisors first reported a position in PPH in Q2 2025 and has held it in 5 quarters since. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

Arkadios Wealth Advisors held 8,469 shares of VanEck Pharmaceutical ETF worth $926K as of Q2 2026.
Arkadios Wealth Advisors bought 22 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $2.28K.
VanEck Pharmaceutical ETF made up 0.01% of Arkadios Wealth Advisors's portfolio in Q2 2026, its #837 holding.
Arkadios Wealth Advisors first reported a position in VanEck Pharmaceutical ETF in Q2 2025 and has held it in 5 quarters since.
148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Arkadios Wealth Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.